< Terug naar vorige pagina
Onderzoeker
Anne Van Hecken
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Klinische Farmacologie en Farmacotherapie (Afdeling)
Lid
Vanaf1 jul 2013 → 31 aug 2020
Publicaties
1 - 10 van 29
- Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers(2019)
Auteurs: Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen
Pagina's: 100 - 110 - Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers(2018)
Auteurs: Jan de Hoon, Anne Van Hecken, Sofie Celen, Guy Bormans, Koen Van Laere
Pagina's: 397 - 404 - Phase 1, Randomized, Double-blind, Placebo-controlled, Single-dose and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine(2018)
Auteurs: Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen
Pagina's: 815 - 825 - Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humans(2018)
Auteurs: Eveline Deloose, Inge Depoortere, Jan de Hoon, Anne Van Hecken, Jan Tack
- Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects(2017)
Auteurs: Jan de Hoon, Anne Van Hecken
Pagina's: 1784 - 1795 - Activation of PAC1 by maxadilan: a new human target engagement biomarker(2017)
Auteurs: Linde Buntinx, Marleen Depré, Els Ampe, Anne Van Hecken, Jan de Hoon
- What we observe in vivo is not always what we see in vitro: Development and Validation of C-JNJ-42491293, A novel radioligand for mGluR2(2017)
Auteurs: Gil Leurquin-Sterk, Sofie Celen, Koen Van Laere, Michel Koole, Guy Bormans, Anne Van Hecken, Alfons Verbruggen, Jan de Hoon
Pagina's: 110 - 116 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers(2017)
Auteurs: Corinne Vandermeulen, Anne Van Hecken, Jan de Hoon
Pagina's: 740 - DEVELOPMENT OF A TARGET ENGAGEMENT BIOMARKER FOR THE PAC1-RECEPTOR IN HUMANS(2016)
Auteurs: Linde Buntinx, M Depre, E Ampe, Anne Van Hecken, G Vargas, K Gabriel, S Sands, Jan de Hoon
Pagina's: 50 - 50 - Translational Pharmacodynamics of Calcitonin Gene-Related Peptide Monoclonal Antibody LY2951742 in a Capsaicin-Induced Dermal Blood Flow Model(2015)
Auteurs: Anne Van Hecken, Jan de Hoon
Pagina's: 350 - 357